Synonyms:
Status: Phase 3
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 720U2QK8I5

Structure

InChI Key PGKXDIMONUAMFR-AREMUKBSSA-N
Smile CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1
InChI
InChI=1S/C31H35Cl2N3O2/c1-23(37)34-31(27-11-7-4-8-12-27)16-19-36(20-17-31)18-15-26(25-13-14-28(32)29(33)21-25)22-35(2)30(38)24-9-5-3-6-10-24/h3-14,21,26H,15-20,22H2,1-2H3,(H,34,37)/t26-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C31H35Cl2N3O2
Molecular Weight 552.55
AlogP 6.37
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 9.0
Polar Surface Area 52.65
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 38.0

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Neurokinin 2 receptor antagonist PubMed PubMed PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Anxiety 3 D001007 ClinicalTrials
Depressive Disorder, Major 3 D003865 ClinicalTrials
Depressive Disorder 3 D003866 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 142001-63-6
ChEMBL CHEMBL308148
DrugBank DB06660
EPA CompTox DTXSID00161923
FDA SRS 720U2QK8I5
Guide to Pharmacology 3481
PubChem 104974
SureChEMBL SCHEMBL185911
ZINC ZINC000003927605